Progress in periventricular leukomalacia

Archives of Neurology

Volumn 65, Issue 10, 2008, Pages 1291-1295

  Deng, Wenbin ^a,b   Pleasure, Jeanette ^b   Pleasure, David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ACETYLCYSTEINE; CYTOKINE; ERYTHROPOIETIN; FREE RADICAL; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MAGNESIUM SULFATE; MINOCYCLINE; PLACEBO; TOPIRAMATE;

BRAIN INJURY; CEREBRAL PALSY; COGNITIVE DEFECT; COOLING; DISEASE MODEL; DISEASE SEVERITY; ECHOGRAPHY; ENCEPHALOMALACIA; GRAY MATTER; HUMAN; LOW BIRTH WEIGHT; MICROGLIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SURVIVOR; TREATMENT FAILURE; WHITE MATTER;

ANIMALS; BRAIN; ENCEPHALITIS; FEMALE; GLIOSIS; HUMANS; INFANT, NEWBORN; LEUKOMALACIA, PERIVENTRICULAR; MAGNETIC RESONANCE IMAGING; MICROGLIA; NERVE FIBERS, MYELINATED; NEURAL PATHWAYS; OLIGODENDROGLIA; OXIDATIVE STRESS; PREGNANCY;

EID: 54049130467     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.10.1291     Document Type: Review

References (33)

1. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke. 2007;38(2)(suppl):724- 730.
2. McQuillen PS, Ferreiro DM. Perinatal subplate neuron injury: implications for cortical development and plasticity. Brain Pathol. 2005;15(3):250-260.
3. De Vries LS, Van Haastert I-LC, Rademaker KJ, Koopman C, Groenendaal F. Ultrasound abnormalities preceding cerebral palsy in high-risk preterm infants. J Pediatr. 2004;144(6):815-820.
4. Inder TE, Huppi PS, Warfield S, et al. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol. 1999;46(5):755-760.
5. Nagae LM, Hoon AH Jr, Stashinko E, et al. Diffusion tensor imaging in children with periventricular leukomalacia: variability of injuries to white matter tracts. AJNR Am J Neuroradiol. 2007;28(7):1213-1222.
6. Vollmer B, Roth S, Baudin J, Stewart AL, Neville BG, Wyatt JS. Predictors of long-term outcome in very preterm infants: gestational age versus neonatal cranial ultrasound. Pediatrics. 2003;112(5):1108-1114.
7. Collins MP, Lorenz JM, Jetton JR, Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res. 2001;50(6):712-719.
8. Wiswell TE, Graziani LJ, Kornhauser MS, et al. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation. Pediatrics. 1996;98(5):918-923.
9. Galli KK, Zimmerman RA, Jarvik GP, et al. Periventricular leukomalacia is common after neonatal cardiac surgery [published correction appears in J Thorac Cardiovasc Surg. 2004;128(3):498]. J Thorac Cardiovasc Surg. 2004;127(3):692-702.
10. Kinney HC, Panigrahy A, Newburger JW, Jonas RA, Sleeper LA. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Acta Neuropathol. 2005;110(6):563-578.
11. Soul JS, Hammer PE, Tsuji M, et al. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res. 2007;61(4):467-473.
12. Ballabh P, Braun A, Nedergaard M. Anatomic analysis of blood vessels in germinal matrix, cerebral cortex, and white matter in developing infants. Pediatr Res. 2004;56(1):117-124.
13. Billiards SS, Haynes RL, Folkerth RD, et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol. 2006;497(2):199-208.
14. Monier A, Adle-Biassette H, Delezoide AL, Evrard P, Gressens P, Verney C. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J Neuropathol Exp Neurol. 2007;66(5):372-382.
15. Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355(4):354-364.
16. Crowther CA, Hiller JE, Doyle LW, Haslam RR; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290(20):2669-2676.
17. Wyatt JS, Gluckman PD, Liu PY, et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics. 2007;119(5):912-921.
18. Itoh T, Beesley J, Itoh A, et al. AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem. 2002;81(2):390-402.
19. Horiuchi M, Itoh A, Pleasure D, Itoh T. MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells. J Biol Chem. 2006;281(29):20095-20106.
20. McQuillen PS, Sheldon RA, Shatz CJ, Ferreiro DM. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci. 2003;23(8):3308-3315.
21. Yang J, Wu EX. Detection of cortical gray matter lesion in the late phase of mild hypoxic-ischemic injury by manganese enhanced MRI. Neuroimage. 2008;39(2):669-679.
22. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter [published correction appears in J Neurosci. 2001;21(5):1a]. J Neurosci. 2000;20(24):9235-9241.
23. Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci. 2004;24(18):4412-4420.
24. Deng W, Wang H, Rosenberg PA, Volpe JJ, Jensen FE. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A. 2004;101(20):7751-7756.
25. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci. 2007;10(3):321-330.
26. Káradóttir R, Cavelier P, Pergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature. 2005;438(7071):1162-1166.
27. Paintlia MK, Paintlia AS, Barbosa E, Singh I, Singh AK. N-Acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004;78(3):347-361.
28. Fan LW, Pang Y, Lin S, et al. Minocycline reduces lipopolysaccharide- induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res. 2005;82(1):71-82.
29. Cai Z, Lin S, Fan LW, Pang Y, Rhodes PG. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience. 2006;137(2):425-436.
30. Li WW, Setzu A, Zhao C, Franklin RJM. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol. 2005;158(1-2):58-66.
31. Gordon PH, Moore DH, Miller RG, et al; Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6(12):1045-1053.
32. Keller M, Yang J, Griesmaier E, et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis. 2006;24(2):357-366.
33. Kumral A, Baskin H, Yesilirmak DC, et al. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neonatology. 2007;92(4):269-278.